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Abstract. Neocortical neuroblast cell lines were used 
to clone G-protein-coupled receptor (GPCR) genes to 
study signaling mechanisms regulating cortical neuro- 
genesis. One putative GPCR gene displayed an in situ 
expression pattern enriched in cortical neurogenic re- 
gions and was therefore named ventricular zone gene-! 
(vzg-1).  The vzg-1 cDNA hybridized to a 3.8-kb 
mRNA transcript and encoded a protein with a pre- 
dicted molecular mass of 41--42 kD, confirmed by West- 
ern blot analysis. To assess its function, vzg-1 was over- 
expressed in a cell line from which it was cloned, 
inducing serum-dependent "cell rounding." Lysophos- 
phatidic acid (LPA), a bioactive lipid present in high 
concentrations in serum, reproduced the effect seen 
with serum alone. Morphological responses to other re- 
lated phospholipids or to thrombin, another agent that 
induces cell rounding through a GPCR, were not ob- 
served in vzg-1 overexpressing cells. Vzg-1 overexpres- 
sion decreased the EC50 of both cell rounding and Gi 
activation in response to LPA. Pertussis toxin treat- 
ment inhibited vzg-l-dependent LPA-mediated Gi ac- 
tivation, but had no effect on cell rounding. Membrane 
binding studies indicated that vzg-1 overexpression in- 
creased specific LPA binding. These analyses identify 
the vzg-1 gene product as a receptor for LPA, suggest- 
ing the operation of LPA signaling mechanisms in 
cortical neurogenesis. Vzg-1 therefore provides a link 
between extracellular LPA and the activation of LPA- 
mediated signaling pathways through a single receptor 
and will allow new investigations into LPA signaling 
both in neural and nonneural systems. 
CRITICAL event in the formation of the mammalian 
cerebral  cortex is  the  ordered  generation of its 
neurons from a discrete proliferative region over- 
lying the cerebral ventricles, the ventricular zone (vz)  t (6), 
(Fig. 1). In most mammalian species, neurogenesis occurs 
during fetal life when the vz can be delineated by histolog- 
ical stains, or by brief pulses of 5-Bromo-2'-deoxyuridine 
(BrdU) or [3H]thymidine, which identify neuroblasts un- 
dergoing S-phase (58, 64, 67). Cortical neuroblasts display 
a stereotyped change in their morphology that is linked to 
their proliferation.  During  S-phase  of the  cell  cycle, vz 
neuroblasts appear bipolar, with the cell body at the super- 
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ficial margin of the vz and with processes oriented towards 
the ventricular and superficial (pial) surfaces of the cere- 
bral wall. With the progression of the cell cycle, the neuro- 
blast undergoes "interkinetic nuclear migration" whereby 
its nucleus descends to the ventricular surface during G2, 
its pial process is retracted, and the cell "rounds up" (62, 
63).  After rounding, the cell undergoes mitosis and then 
regains its bipolar morphology to complete the cell cycle 
(Fig. 1 a). In the mouse, cortical neurogenesis is limited to 
the period between embryonic day 11 (Ell) and El8 (9, 
10, 67). Beyond this period, cells are still produced within 
the cerebral wall; however, these cells are generally of glial 
rather than neuronal lineages (4, 10, 22, 32, 67). 
The molecular mechanisms responsible for controlling 
vz neurogenesis are largely unknown. However, three ob- 
servations suggest that it is regulated, at least in part, by 
interactions between  a  neuroblast  and  its  environment, 
rather than through cell-autonomous mechanisms. First, a 
number of growth factors operating through receptor ty- 
rosine kinases (RTKs)  (3,  78),  most notably basic fibro- 
blast growth factor, promote proliferation of telencephalic 
cells in primary culture (8, 30, 44, 70).  Second, uncharac- 
terized serum factors appear to be required in addition to 
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The Journal of Cell Biology,  Volume 135, Number  4, November 1996 1071-1083  1071 Figure 1.  Location and morphologies of mitotic cortical neuroblasts within the vz. (a) The left diagram illustrates the anatomical zones 
in the embryonic cerebral cortex.  Cortical  neurogenesis  is restricted to the proliferative vz (shaded). The right diagram shows the 
changes in proliferating  neuroblast morphology during progression  of the cell cycle within the vz. During S phase, cell nuclei are in the 
outer portion of the vz and then assume a rounded appearance closely apposed to the ventricle (V) by M phase. After mitosis, rounded 
daughter cells regain their bipolar morphology. V, ventricle;  VZ, ventricular  zone; IZ, intermediate zone; CP, cortical plate.  (b) Vzg-1 
mRNA colocalizes with cortical neuroblast proliferation.  Cortical neuroblasts were labeled with a 1-h pulse of BrdU (brown reaction 
product) to identify cells undergoing DNA synthesis (58, 68). Vzg-1 expression was localized in the same section by in situ hybridization 
of an antisense digoxigenin-labeled  vzg-1 riboprobe visualized by immunohistochemistry  (purple reaction product). Note that vzg-1 ex- 
pression is limited to the proliferative zone defined by BrdU labeling. Arrows delineate upper limit of the CNS. Bar, 50 ~m. 
identified growth factors to promote cortical cell prolifera- 
tion (43, 44), consistent with normal cortical development 
in mice with null mutations for known growth factors and/ 
or their receptors (45). Third, cell membranes or cell--cell 
contacts also promote proliferation of telencephalic blasts 
(30, 69). These observations could be explained by the op- 
eration of novel receptors, distinct from RTKs, regulating 
cortical neurogenesis. 
An  attractive candidate  for this  role is the  G-protein- 
coupled-receptor (GPCR)  family. It is crucial  to central 
nervous system (CNS) function (20) and contains many di- 
verse members (7, 57), some of which have known mitoge- 
nic  effects (1,  41,  74).  To isolate GPCR genes, we used 
novel clonal cell lines derived from the vz that resemble 
cortical neuroblasts (14). These cell lines provide a unique 
source of cDNA for cloning strategies and can further be 
used for functional studies of receptor genes, enabling an 
identified receptor to interact with signaling pathways ap- 
proximating those found in vivo. 
Here  we  report  the  complete  sequence  and  develop- 
mental CNS expression pattern of a  new member of the 
GPCR family named ventricular  zone gene-1  (vzg-1) be- 
cause of its restricted expression within the cerebral corti- 
cal vz (Fig. i  b). Based on functional assays, ligand binding 
data, and its tissue distribution, we conclude that vzg-1 en- 
codes a receptor for lysophosphatidic acid (LPA). LPA is 
a phospholipid signaling molecule that has a wide variety 
of effects on many different cell types (see Discussion; for 
recent reviews see 26 and 54). Although LPA almost cer- 
tainly acts through a GPCR, a cDNA clone of this recep- 
tor has not been identified, in part reflecting the chemical 
characteristics of LPA that result in unacceptably high lev- 
els of nonspecific binding, making techniques such as ex- 
pression  cloning  impractical.  Therefore,  the  possibility 
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effects of LPA has been left open (26, 71, 74, 77). To over- 
come  these  difficulties,  we  have  instead  relied  on well- 
defined functional characteristics of LPA signal transduc- 
tion to identify the vzg-1 gene product as a receptor for LPA. 
Materials and Methods 
Cell Culture 
Cell lines TSM and TR (14)  were grown in OptiMEM f  (GIBCO BRL, 
Gaithersburg, MD) with 5% FCS (Hyclone Labs, Logan, UT), 20 mM glu- 
cose, 55 ~zM 2-mercaptoethanol, 1013 U/ml penicillin, and 100 lxg/ml strep- 
tomycin at 37°C, 5% CO2. 
Cell Transfection. Transient transfection used calcium phosphate pre- 
cipitation (12) with a 10:1 molar ratio of vzg-1 expression plasmid to 13-galac- 
tosidase expression  plasmid pCMVJ~ (Clonetech, Palo Alto, CA). After 18 h, 
cells were refed, grown for 24 h, fixed in 4% paraformaldehyde in PBS for 
10 min, and stained for 13-galactosidase  activity (2).  Positive cells (200/ 
plate) were counted "blind." The statistical program Instat (Graphpad 
Software, San Diego, CA) was used for one-way analysis of variance and 
the Student-Newman-Keuls pairwise t-test. Stable transfection used a 10:1 
molar ratio of vzg-1 expression plasmid to pSV2-puro (79)  and selection 
in medium containing 10 I~g/ml puromycin. After 2 wks of selection, single 
colonies of cells were picked using cloning cylinders, expanded, and then 
stored or processed for RNA isolation and Northern analyses as previ- 
ously described (14,19). 
Morphological Assay. Stable cell lines (5,000/well in 24-well plates) were 
serum starved for 24 h, and then media containing the desired agents was 
added  to  the  required  final  concentration.  Cells  were  fixed  in  4% 
paraformaldehyde in PBS to terminate incubation and examined. Experi- 
ments were performed in duplicate (200 cells counted/well) and represen- 
tative samples were evaluated by multiple investigators. Statistical meth- 
ods used were identical to transient experiments. 
cAMP Assay. Cells (30,000)  were plated, serum starved overnight, and 
then stimulated for 7 min at 37°C with serum-free medium containing 200 
/xM 3-isobutyl-l-methylxanthine, 10 ~M isoproterenol, and LPA. cAMP 
accumulation was measured as described (55). Data were analyzed using 
Prism (Graphpad Software). 
Pertussis Toxin (PTX) Treatment. Ceils  were  treated  with  200  ng/ml 
PTX for 16 h, followed by a 3-h treatment with fresh PTX. 
Molecular Biological Techniques 
PCR Amplification of GPCR Family Members. Poly-A+ RNA was isolated 
from TR and TSM cells (twice selected on oligo-dT cellulose |Pharmacia 
LKB Biotechnology, Piscataway, NJ]) (2) and 10.5 trg of RNA was re- 
verse transcribed using oligo-dT or random hexamer primers in 50 mM 
Tris, pH 8.3, 6 mM MgCI2, 40 mM KC1, 1 mM DTr, 1 mM each dNTPs, 
and  10  U/Ixl  Moloney  murine  leukemia  virus  reverse  transcriptase 
(GIBCO BRL).  RNA and primers were heated to 65°C  (5 min), then 
cooled to room temperature (RT). Additional reagents were added, and 
then heated to 37°C (2 h). This cDNA was PCR amplified using a degen- 
erate primer set derived from the conserved regions of transmembrane 
(TM) domain If and VII of the GPCR family (7). PCR reactions used 40 
ng of eDNA in 10 mM Tris, pH 8.3, 50 mM KCI, 2 tLM of each primer, 1.5 
mM MgCI2, 0.2 I~M each dNTPs, and 2.5 U Taq DNA polymerase. All 30 
pairwise combinations of primers were used. Reactions were placed in a 
Perkin-Elmer 480  thermal cycler (Applied Biosystems, Inc., Foster City, 
CA) at 94°C (3 min) and then cycled 25-40 times at 96°C (45 s), 47°C (144 s) 
or 53°C (216 s), and 72°C (3 min, 6 s extension/cycle). Products were T/A 
cloned (53), screened by in situ hybridization, and sequenced. The product 
used to  clone vzg-1 ("513")  was  independently isolated using TM  II 
primer 5 'AA(C/r)T(A/G)(C/G)ATI(A/C)TI(C/G)T/AA(c/r)(c/F)TIGC- 
IGTIGCIGA and TM VII primers 5'CTGI(CZF)(G/T)(A/G)TI'CATIA(A/ 
T)I( A/C)(A/C)(A/G)TAIA(CFF)IA(CJF)IGG(AIG)TI',  5'TCIAT(AJG)- 
Tr(A/G)AAIGTIGT(A/G)TAIATIATIGG(A/G)TT,  and  5'AA(A/ 
G )TCI  GG(  AfG  )(  CIG  )( A/T)ICGI ( C/G  ) A ( AIG  ) T A IA  T (  C/G  ) AII  GG(  AI 
G)TT. 
Full-Length Vzg-1 cDNA Cloning. Clone  "513"  was  used  to  screen 
500,000 phage plaques at high stringency from a postnatal day 20 BALB/c 
(same strain as cell lines TR and TSM) mouse brain library (Stratagene, 
La Jolla, CA). Clone "pSt3," containing a 2,250-bp insert, was sequenced 
completely in both directions by the dideoxy chain termination method 
(2). Sequence analysis used BLAST (NCBI, Bethesda, MD), MacDNAsis 
(Hitachi Software, San Bruno, CA), and the GCG programs (Genetics 
Computer Group, Madison, WI). 
Expression Vectors. Vectors for transfection contained the 1,131-bp Ear 
l-Nae I vzg-1 open reading frame fragment from pSt3 in the sense or anti- 
sense orientation, blunt-end cloned into the EcoRV site of pcDNAI/Amp 
(InVitrogen, San Diego, CA) by standard protocols (2). Thrombin recep- 
tor expression vector (37) was kindly provided by Dr. S. Coughlin (Uni- 
versity of California San Francisco). 
RNA Isolation and Northern Analysis. These methods have been previ- 
ously described (2,14,19). 
Histology 
In Situ Hybridization. In  situ  hybridization to  BALB/c  mouse  embryos 
was performed as previously described using digoxigenin-labeled ribo- 
probes visualized by alkaline phosphatase histochemistry (19, 73). 
BrdUlIn Situ Hybridization Double Labeling. Timed  pregnant  BALB/c 
mice were injected intraperitoneally with 20  i~l  I0  mM BrdU/g body 
weight 1 h before sacrifice. In situ hybridization and probe visualization 
were immediately followed by HCI incubation (60~C in 1 N HC1,15 rain), and 
slides were washed in PBS (RT, 10 rain, 3×), incubated in blocking solu- 
tion (RT, 2.5% BSA, 0.3% Triton X-100,  1× PBS, 1 h), and then incu- 
bated in 6 }xg/ml mouse monoclonal anti-BrdU antibody (RT, 1 h) (Boeh- 
ringer-Mannheim Corp., Indianapolis, IN). Bound antibody was visualized by 
anti-mouse Vectastain ABC peroxidase kit (Vector Laboratories, Burlin- 
game, CA) as previously described (15-18). 
Phospholipid Sources and Receptor-Ligand Binding 
Lipids (1-oleoyMysophosphatidylethanolamine [LPE], 1-oleoyl-lysophos- 
phatidylglycerol [LPG], 1-oleoyl-lysophosphatidylcholine  [LPC], 1, 2-dio- 
leoyl-phosphatidic acid [PA], 1-stearoyl-LPA, and  1-oleoyl-LPA) were 
obtained  from  Avanti  Polar  Lipids  (Alabaster,  AL).  Labeled  ligand 
(1-oleoyl-[9,10-SH]-LPA; Dupont/NEN,  Boston, MA) was prepared by 
evaporating >50% of the solvent under a N2 stream and reconstituting the 
volume with 100% ethanol All lipids were synthetic, 98-99% pure. 
Membrane Isolation and [3H]LPA Binding Assay. Cell lines were grown 
to 90% confluence, washed with PBS, scraped from the plate, centrifuged 
for 5 rain (110 g), washed with PBS, recentrifuged, and the pellet then re- 
suspended in 10 ml of ice-cold 20 mM Tris, pH 7.5, disrupted by 20 strokes 
in a glass homogenizer, and sonicated on ice with three 10-s bursts using a 
microultrasonic cell disrupter (Kontes Glass, Hayward, CA). After low 
speed centrifugation (1,000  g,  15  min, 4°C), membranes were pelleted 
from the supernatant (16,000 g, 30 rain, 4°C), and resuspended at 3 p,g/p,l 
protein in ice-cold 20 mM Tris, pH 7.5. Just before analysis, membranes 
were resonicated for 5 s on ice until the solution became transparent, then 
LPA binding assays carried out as previously described (71). Briefly, bind- 
ing reactions (500 ixl of 50 ixg/ml membrane protein in an assay buffer of 
20 mM riffs, pH 7.5, and 0.5 mM CuSO4) were initiated by addition of l-ole- 
oyI-[9,10-SH]-LPA  (56.2  Ci/mmol)  to  a  final concentration of 8.5  nM 
(230,000  cpm) and incubated (30°C, 30 min). To assess nonspecific bind- 
ing, 2 p~M unlabeled 1-oleoyl-LPA was added to a set of parallel reactions. 
Reactions were run through PD-10 Sephadex G25M columns (Pharmacia 
LKB Biotechnology) to separate bound from free ligand. The eluent (1.5 
ml) was mixed with scintillation fluid (Ultima Gold; Packard Instrument 
Co., Inc., Meriden, CT) and counted at RT. About 5-10% of the total in- 
put cpm were collected in the eluent. Uncorrected total binding ranged 
from 13,000 to 20,000 cpm. Because LPA forms aggregates that are ex- 
cluded from the column bed and thus collected in the eluent, each experi- 
ment was performed in parallel using reactions without membranes, in the 
presence or absence of 2 IxM LPA, to determine eluted background cpm. 
Total and nonspecific cpm were corrected by subtraction of the appropri- 
ate background cpm. Specific cpm were calculated by subtracting cor- 
rected nonspecific  cpm from corrected total cpm. Overall, with correction, 
nonspecific cpm were 61% of total clam. Experiments were done in tripli- 
cate and the results statistically analyzed using Student's t-test. 
Antiserum Production and Western Blot Analysis 
A rabbit polyclonal antiserum was raised against Vzg-1 by eDNA vaccina- 
tion (25, 60). Twice weekly intradermal injections of vzg-1 expression con- 
struct (20 p~g) in PBS for 6 wk were followed by a week hiatus (test bleed) 
and then injections repeated for 4 wk and serum collected. Cells were se- 
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'I%K~ACCT GC~AC~AGCA~%CCGAGATCTGATCAC~  C  G~TTGe.i.FFFI~IW,  CCTC.GC  ACTGCAG  TGC  AGGGG~ ~ 
201 TTCA~%'GCCCCAAACTACAGCAC~ 
221  MA  AA  S  T  S  S  PV  I  S  Q  PQ  F  TAMN  E  Q  Q  C  F  y~E  S  i  A  F  F 
A~C-AGCTGCCTCrACTTCC^GCCCrGT~TTTC^~C~TrCACaGCCAaV,~eG~AC~CaGaVam-rC-r^C~G~A~  C~ 
TMI 
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327 TATAACCGGAG~/WaC~TATCTAGC CACAG~TGGAACACAGT~A~-I%~IIt4ATGGGAL.I~%,I.ascj~.PCAL.I  ~  ~q~ ~  A~A~  ~ 
V  V  ,  TM  II  V  V  V 
67  IN'  L  n  VIM  V  A  I  Y  V  N  R  R  ~F  H  F  P  ~  Y  Y  b  M  A  N  L  A  A  A  D  F  F  A  G I 
426 AATCTCCTGGTCATGGTGGCAATCTA~GTC~ACCG~ATTTCCCTATTTATTA~F1~ATGGCCAAC~TGCAGACTTCTT~ 
100 k~.~  M  F  N  T  G  P  N  T  R  R  b  T  V  S  T  IW  L  L  R  0  G  L  I  D  T  S  L l 
525 ~FI~CTACTTCTXCC~TGTTCAATACAGGACCTAATACCCGGAGACTGACTGTTA~~~A~~CACCA~ 
TM  III  V 
133  IT-  A  S  V  A  N  L  n  %  ~  A  ~I  E  R  H  I  T  V  F  R  M  O  L  H  T  a  M  I  s  N  R  R  V  V] 
624 ACAGCT~CAACCT~ATTC~ATCGAGAGGCACATCACu~FFF~CGCATGCAGCTCCATACACGAATGAGCAACCGGCGCGTC~ 
TM IV  v  v 
166  l~  V  I  V  V  I  W  T  M  A  I  ~  ~  ~  ~  ~IS  V  G  W  N  ~"  I  ~'DIDH~SNM 
723 GTC,  GTGATTGTAGTCATC~CTATC~TTGTGATGGGT~ATAC~GTGT~  TGGAA~ ~TA~GA  ~ AC  T  GT  ~ C~C A~ 
199  A  P  L  Y  S  D  IS  Y  L  V  F  W  A  I  ~  N  V  T  F  V  V  M  V  V  L~ Y  A  H  I  F  G  Y 
822 GCACCCCTCTACAG~PGACTCCTACTTAGTC~CA~FFFx%/AACC~ACCT~ATGG~TTCTCTACC~CTCACATCTTTGGCTAT 
232  V  R  Q  R  T  M  R  M  S  R  H  S  S  G  P  R  R  N  R  D  T  M  M  S  ~  L  K  T  V  V  I  V  LI 
921 GTTCGCCAGAGGACTATGAGGAT~GGCATAGT~CCCAGGAGGAATCGGGACACCATGATGA~~c  ~A~ 
v  T  M vI  v  v 
265[G  A  F  I  V  C  W  T  ~  G  L  V  L  r',  L  LID  V  ~-~p  O  ~'O  V  15  A  y  E  K  F  ~  ~j 
1020 GGTGCCTTTATTGTCTGCTGGACTCCGGGATTC~"~CTTG~/~ATTGCTG~ATGTGTGCTGCCCGCAGTGCGATGTCCTGC42CTATGAGAAGTTCTTC~ 
TM VII  W  V  V  •  •  • 
298  |L  &  ~  E  F  N  @  ~  M  N  ~  I  I[ Y  S  Y  R  D  K  E  M  S  A  T  F  R  Q  I  L  C  C  Q  R 
1119 CTCCTGGCCGAGTTCAA~AT~AAcCCCATCATCTACTCCTAC~GCGACAAAGAGATGAGCGCCACCTTCA~AGA~C~GCCA~ 
331  N  E  N  P  N  G  P  T  E  G  S  D  R  S  A  S  S  L  N  H  T  I  L  A  G  V  H  S  N  D  H  S  V 
1218 AACGAGAA~C~TAA~M~`=CCCCACGGAAGGCTCTGAC~GCTCTGCCTCCTCCCTCAACCACAC~ATTC~TGGAGTTCA~AG~AACGACCAC~  ~ 
364  V  * 
1317 GTTTAG 
1323 AAGGAAGCCAGCCGGCCTCTGTGGATCTGTGAACCCCACCCTACCCCCCATTGCCA•GGCAAGGTGGGGAC•CCAGAGGAGATGAGGACACTCCTGTACTT 
1423 AACACTAACCAATGGCAGTATTTGTCCCTAGACC  TGAAT/TATTTGGCAGC,  CCCCATCTTCTCCTTTGGAAAACAGAAGGGGACC 
1523 G'~C  T'I~AATTGAGAAATGGACT~~AC~CATTCACTAACTAGACTTAAAAGATTTTA  AAGCCAGGAAAAA 
1623 AAAATCT~AATTGAGTATACAA%~GAGTATAC~CTTTAAAGAACAAACAATACA~GCA~'~TATTAATGAGTATGTTTATGCCTGAC 
1723 AGCATGTTTGTGATCGAAAAGACTGCT~TGACATAGATGAGTTG~*~*T~-r~x~F~-~*~`~*~L~FF~F~L~FF~FFrACATGATGGAGGAAAAGTATAAA 
1823 TTAGAATGA'FFFF~'GTGTT~AC~  ATTC-AGTATG~%."FF£~%GATAAAAGGCCACTATTTTAAATC  TTCTAG 
1923 GGAAT*%~TATCCTAATCAATTACCTTTTAATTAAAGTAATGAAATATACATGA 
2023 AAG~,CAAAGTAATG~GC~  .CGCTC~TGAAGCTGTAGCGTTGTCCCTGCATAGTGAAGATAC  CCA 
2123  CG'~G~.G~GACC  AAAG~I-FF~t~CAAGTTAGA~TAATACCTACTTACTATAGAA~CTTGAAAAT 
2223 TGCAGAACTGT(~ 
b 
100  200  300  364 
.~nino ;~tcl I~A~n 
Figure  2.  Vzg-1 encodes  a 
GPCR.  (a)  Nucleotide  and 
predicted  aa  sequences  of 
vzg-1. The 2,250-bp sequence 
contains  a  1,095-bp  open 
reading  frame,  extending 
from bases 228--1322, (*, stop 
codon).  There  are  two  in- 
frame stop codons located 5' 
to the translational start site 
at positions 33 and 144 of the 
nucleotide  sequence.  Posi- 
tions  of  TM  domains  I 
through  VII are  boxed  (see 
b).  Vzg-1  has  conserved  aa 
residues  shared  amongst 
many  members  of  the 
GPCR family (v) (57). Other 
common features are N-linked 
glycosylation  sites  (circled) 
(24,  59),  cysteine  residues 
that  may  form  disulfide 
bonds  (overlined) (42),  and 
cysteine residues that can po- 
tentially  be  lipid-modified 
(,) (80).  Multiple serine and 
threonine  residues  in  the 
third  intracellular  loop  and 
COOH-terminal  intracellular 
domain are potential sites for 
regulatory  phosphorylation 
(31).  These  sequence  data 
are available from GenBank/ 
EMBL/DDBJ  under  acces- 
sion  number  U70622.  (b) 
Kyte-Doolittle  hydrophobic- 
ity analysis  of Vzg-1  (46)  re- 
veals seven putative TM do- 
mains. Positive values indicate 
hydrophobicity,  while  nega- 
tive  values  indicate  hydro- 
philicity. The plot was calcu- 
lated using a window of 15 aa. 
rum starved 24 h  and membranes were prepared as above, except that 
buffers contained 1 mM EGTA, 1 mM PMSF, and 1 mM benzamidine. 
Western blot techniques were as previously described (15,  16). Briefly, 
membrane proteins were solubilized in 1×  sample buffer (2), separated 
on 15% SDS-PAGE minigels, electroblotted onto nitrocellulose (Scblei- 
cher & Schuell, Inc., Keene, NH), and incubated overnight (RT) with 1: 
100 dilution of primary antiserum. Bound antibody was detected using the 
Vectastain ABC kit (Vector Laboratories, Burlingame, CA) using DAB 
visualization. 
Results 
Vzg-1 Encodes a Novel Seven-Transmembrane 
Domain Molecule 
Degenerate  oligonucleotide  primers  against  amino  acid 
(aa) sequences from TM II and TM VII of the GPCR fam- 
ily (7, 48)  were used in PCR  amplification  of neocortical 
cell  line  cDNA  (lines  TR  and  TSM  (14);  Materials  and 
Methods). A  total of 154 DNA fragments representing 58 
distinct PCR products in the expected size range from 600 
to 1,300 bp were cloned.  One fragment,  "5•3,"  was local- 
ized to the vz (Fig.  1 b) by in situ hybridization  and was 
represented  by  13  independently  derived  clones  having 
GPCR  aa sequence  homology.  Northern  blot  analysis of 
embryonic  brain  detected  a  single  3.8-kb  transcript.  Li- 
brary screening led to isolation of a 2.4-kb cDNA, termed 
vzg-1, containing  an open reading frame (Fig. 2 a) encod- 
ing  a  41-kD  protein  with  seven  hydrophobic  membrane 
spanning  domains  (Fig.  2  b), as well as other features  of 
the  GPCR  family.  Comparisons  to  published  sequences 
(data not shown) demonstrated  that Vzg-1 shared homol- 
ogy with the melanocortin receptor (32% aa identity) (23), 
cannabinoid  receptor  (30%  aa identity)  (52),  and the  or- 
phan receptor gene edg-1 (37% aa identity) (36). 
Vzg-1 Expression Correlates with 
Cortical Neurogenesis 
The full-length vzg-1 clone hybridized to a transcript iden- 
The Journal of Cell Biology, Volume 135, 1996  1074 Figure 3.  Vzg-1  is expressed in the embryonic mouse brain and in 
neocortical  neuroblast cell lines. Total RNA (10 p,g) from mouse 
brains at E13-E17 and cytoplasmic RNA from cell lines TSM and 
TR were analyzed by Northern blot analysis using a vzg-1 probe. 
The vzg-1 transcript is 3.8 kb (~/-actin loading control is shown). 
tical in size to that identified by fragment 513, which was 
present in the embryonic mouse brain and in the cell lines 
from which  it was cloned  (Fig. 3).  Vzg-1 expression was 
examined in mouse embryos from El2 to El8 by in situ 
hybridization. A  low magnification view (shown for El4) 
demonstrated that, within the CNS, vzg-1 expression was 
highly enriched within the cerebral cortical vz in the dorsal 
telencephalon.  Additional  hybridization  is observed to  a 
tissue layer closely apposed to CNS, likely to be a develop- 
ing meningeal layer (Fig. 4, a and b). 
Vzg-1 was  expressed throughout  most of the  cerebral 
wall at El2, when it consists mainly of proliferative neuro- 
blasts (Fig, 5). As this wall thickens with further develop- 
ment,  vzg-1 expression  remained  primarily restricted  to 
the proliferative vz (Fig. 5; see also Fig. i  b). The vzg-1 hy- 
bridization signal appeared most intense at E12 and El4, 
somewhat less at El6,  and was barely detectable at El8, 
Thus, vzg-1 expression is primarily restricted to the vz of 
the cerebral cortex during neurogenesis. 
Vzg-10verexpression Induces Sustained, 
LPA-dependent Cell Rounding 
To determine possible functions of vzg-1, cell line TSM, 
chosen for its comparatively low expression of the endoge- 
nous  transcript  (Fig.  3),  was transiently  transfected with 
expression vectors containing vzg-1 in  the  sense or anti- 
sense  orientation.  Transfection with  the  vzg-1 sense  ex- 
pression vector induced neurite retraction and cell round- 
ing,  which  was  maintained  for  at  least  24  h  (Fig.  6  a, 
"sustained cell rounding"). This morphological change re- 
quired the presence of serum. Sense transfected cells ex- 
posed to serum had 48  +  3.6%  round morphology, com- 
pared to 22 +  5.0% without serum (Table I). 
The reproducibility of cell rounding allowed its use as a 
bioassay to identify putative ligands for vzg-1. Boiling the 
serum did not abolish its ability to mediate cell rounding 
(data not shown), indicating that the ligand was a heat sta- 
ble molecule that might be associated with (a) cytoskeletal 
changes and (b) cell proliferation, since vzg-1 expression 
was restricted to the vz. A  molecule present in serum that 
met these criteria (see Discussion) was LPA. Since endog- 
enous Vzg-1 should be active in the cell lines from which it 
was identified, untransfected TSM cells were first assayed 
for their ability to respond to LPA. Indeed, TSM cells re- 
sponded with a rapid increase in the percentage of round 
cells. However, this response was reversible such that by 
3 h, the percentages of round cells returned to their base- 
line values (Fig. 6 b). 
Transfection of TSM cells with vzg-1 in the sense orien- 
tation sustained the rounding response to LPA such that 
at 3 h, 49 +_ 4.9% of treated transfected cells still displayed 
a round morphology, compared to 29 __ 1.9% of untreated 
transfected cells (Table I). Importantly, thrombin, a serum 
component which also induces cell rounding in some neu- 
ral cell lines (38, 66), did not induce sustained cell round- 
ing in cells transfected with vzg-1, although it did induce 
sustained cell rounding in cells transfected with the throm- 
bin receptor (Table II). Thus, transient overexpression of 
vzg-1  specifically  alters  LPA-mediated  changes  in  cell 
morphology. 
Vzg-I Overexpressing Cell Ones Show Morphological 
Responses Specific to LPA 
Vzg-1  function  was  characterized  in  TSM  cells  stably 
transfected with the vzg-1 sense construct, using the anti- 
sense construct and empty vector as transfection controls. 
(Stably transfected cell lines will be referred to as "sense, 
empty vector, or antisense cells.") Overexpression of vzg-1 
in sense cells was at least fivefold over endogenous expres- 
sion, and in antisense cells at least twofold over endoge- 
nous  expression,  determined  by  Northern  analysis  and 
scanning densitometry (data not shown). Vzg-1 protein in 
sense cells  (line 3)  was overexpressed relative  to  empty 
vector (line 33) or antisense (line 17) cells (Fig. 7 a). Sense 
cells, but not empty vector or antisense cells, responded to 
LPA by sustained cell rounding at 3 h (Fig. 7 b). 
The specificity of the LPA response in vzg-1 sense cells 
was tested using a  range of structurally related phospho- 
lipids.  Two forms of LPA,  1-oleoyl-LPA and  1-stearoyl- 
LPA, were examined along with four other structurally re- 
lated  lipids:  1-oleoyl-LPC,  1-oleoyl-LPE,  1-oleoyl-LPG, 
and  1, 2-dioleoyl-PA (Table III). Compared to the other 
phospholipids,  only  LPA  lipids  produced  sustained  cell 
rounding after 3 h of treatment, and thus the response was 
specific to LPA. 
Vzg-10verexpression Decreases the ECso of 
LPA-induced Cell Rounding 
The cell rounding bioassay was used to determine the ef- 
fect of LPA concentration on sense, antisense, and empty 
vector cells. Concentration-response experiments defined 
the  EC50, minimal,  and  maximal response  values  of the 
morphological response to LPA (Fig. 7 c and Table IV). 
Sense cells displayed a  similar maximal response to LPA 
as empty vector cells, but were 6.9-fold more sensitive, as 
demonstrated  by  a  shift  in  the  concentration-response 
curve to the left. In contrast, antisense cells displayed de- 
creased basal and maximal responses but equal sensitivity 
Hecht et al. Lysophosphatidic Acid Receptor  in Cortical  Development  1075 Figure 4.  Vzg-1 expression in the embryonic CNS is enriched within the vz. Low magnification view of adjacent sagittal (a, c, and e) and 
coronal (b, d, and j~ sections of El4 mouse embryo hybridized to antisense (a and b) or sense control (c and d) digoxigenin-labeled  ribo- 
probes, or stained with cresyl violet (e and f). The hybridization  pattern produced by the antisense probe is restricted to the neuroprolif- 
erative vz of the embryonic cortex. Ctx, cortex; LV, lateral ventricle; OB, olfactory bulb; SA, striatum; Th, thalamus; T, tectum; P, pons; 
Cb, cerebellum; M, medulla; GE, ganglionic eminence; TV, third ventricle; POA, preoptic area; d, dorsal; r, rostral; rn, medial. Bar, 1 mm. 
The Journal  of Cell Biology,  Volume 135, 1996  1076 Figure 5.  Developmental expression of vzg-1 parallels the anatomical location and period of cortical neurogenesis. SagittaI sections of 
the cortex from E12-E18 hybridized to antisense vzg-1 riboprobe (a, c, e, and g) compared to an adjacent section stained with cresyl vi- 
olet (b, d, f, and h). Vzg-1 expression is largely confined to the vz throughout this period. Vzg-1 appears highly expressed at E12 and 
E14, less so at E16 and at minimal levels at E18. vz, ventricular zone; iz, intermediate zone; cp, cortical plate; mz, marginal zone; v, ven- 
tricle. Bar, 50 i~m. 
as control cells. Two other sets of independently  derived 
cell lines  showed similar  results  (data  not shown).  Thus, 
overexpression of the sense vzg-I construct specifically in- 
creased the potency of LPA, a result consistent with vzg-1 
encoding a receptor for LPA. 
Vzg-10verexpression Decreases the ECso of 
LPA-stimulated Gi Activation 
To examine  whether  vzg-1  overexpression  altered  LPA- 
mediated G  i activation, sense, antisense, and empty vector 
cells were tested for LPA-stimulated  inhibition of cAMP 
accumulation.  As  shown  in  Table  IV, the  ECs0 in  sense 
cells  was reduced  6.6-fold relative  to empty vector cells. 
Antisense  cells  had  a  similar  ECs0 as  empty vector cells. 
The effect of LPA on cAMP accumulation was reversed 
by PTX  treatment,  indicating  activation  of Gi;  however, 
PTX treatment  did not affect LPA-induced cell rounding 
(Table V). The effect of vzg-1 on LPA-mediated Gi activa- 
tion was specific to LPA since adenylate cyclase inhibition 
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TSM Cells Transiently Transfected with Vzg-1 
5% FCS (percent round,  1 p~m LPA (percent 
mean _+ SEM)  round, mean -~ SEM) 
Expression vector  +  -  +  - 
Vzg-lsense  48_+3.6"  22±5.0  49-+4.9"  29_+  1.9 
Control: vzg-1 antisense  20 _+ 0.88  23 ±  2.2  27 -+ 2.1  24 _+  1.3 
Control: empty vector  21  _  6.0  23 --- 4.2  ND  ND 
Ceils were u'ansiently transfected  with the indicated  expression  vectors, followed by 
treatment with either FCS for 24 h or LPA for 3 h. Data represent the mean + SEM for 
three to four independent experiments, each done in duplicate. 
*Indicates statistically significant differences  from control conditions ( P <  0.001 ). 
Figure 6.  LPA induces  cell rounding and neurite  retraction in 
TSM  cells. (a)  Transfected cells,  identified  by [3-galactosidase 
staining, either have round morphologies (arrows) or pyramidal 
or bipolar morphologies.  Bar, 50 Ixm. (b) LPA response of un- 
transfected TSM cells. Within 15 min, LPA caused an increase in 
the proportion of round cells. Note that the proportion of round 
cells returns to baseline  after 3 h, allowing transfection  experi- 
ments to be carried out on this time scale. Values represent the 
mean _+ SEM of three independent experiments,  each done in 
duplicate. 
mediated by UK14304, an a2-adrenergic receptor agonist, 
did  not  show  differential  effects on  sense  and  antisense 
overexpressing cells (data not shown). 
Vzg-10verexpression Increases LPA Binding in 
Cell Membranes 
The use of binding assays with [3H]LPA to study ligand- 
receptor interactions is complicated by the lipophilic and 
detergent properties of LPA (26, 71, 74,  77), resulting in 
substantial nonspecific and background binding (see Ma- 
terials and Methods).  Nevertheless,  [3H]LPA binding as- 
says  were  performed  on  membrane  preparations  from 
sense  and  antisense  cells  to  determine  whether  overex- 
pression of vzg-1 increased the number of specific [3H]LPA 
binding sites. Membrane preparations derived from sense 
cells showed  a  statistically significant increase in  specific 
[3H]LPA binding compared to membranes from antisense 
lines (Fig. 7 d). This result demonstrated that vzg-1 over- 
expression is associated with an increase in the number of 
binding sites for [3H]LPA. 
Adult Expression of Vzg-1 Parallels Prior Estimates of 
LPA Receptor Distribution 
Prior studies examining the distribution of LPA receptors 
demonstrated that in adult tissues, receptors are present at 
very high levels in the brain, are virtually absent from the 
liver, and are present at intermediate levels in other tissues 
(71,  77).  Additionally,  high  levels  of  receptor  are  ex- 
pressed in NIH-3T3 cells. Northern blot analysis (Fig. 8) 
demonstrated that vzg-1 was expressed at maximal levels 
in the adult brain, absent from liver, and present at inter- 
mediate levels in other tissues, a pattern paralleling these 
previous results. Vzg-1 was also highly expressed in NIH- 
3T3 cells (data not shown). 
Discussion 
LPA Meets Criteria Expected for a Vzg-1 Ligand 
Functional analyses of vzg-1 required ligand identification, 
a  difficulty underscored by the huge variety of molecules 
recognized by the GPCR family (80). Ligand identification 
was aided by three observations from our study. First, vzg-1 
Table II. LPA, but Not Thrombin, Stimulates Vzg-l-dependent 
Sustained Cell Rounding 
Control: no 
1 IzM LPA  0.5 U/ml thrombin  treatment 
(percent round,  (percent round,  (percent round, 
Expression vector  mean -+ SEM)  mean -+ SEM)  mean -+ SEM) 
Vzg-1 sense  47 _+ 2.2*  23  -+ 4.1  23 ±  4.3 
Thrombin  32 ±  2.0  76 ±  2.1"  28 ±  2.3 
receptor 
TSM cells were transiently transfected  with the indicated expression  vectors followed 
by treatment with either LPA for 3 h or thrombin for 2 h. Data represent the mean -+ 
SEM for three independent experiments, each done in duplicate. 
*Indicates statistically significant differences from control conditions (P <  0.001 ). 
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some aspect of cortical neurogenesis (see below). Second, 
vzg-l-dependent,  serum-induced, sustained cell rounding 
was  highly  reproducible,  allowing  its  use  as  a  bioassay. 
Third,  the  serum  factor inducing  cell rounding  was  heat 
stable. Prior studies reported that cortical blast prolifera- 
tion required (a) cell membrane extracts or cell-cell con- 
tact  (30,  69)  and  (b)  serum  (43,  70).  Thus,  ligand(s) for 
Vzg-1 could (a) be involved in cell proliferation or differ- 
entiation,  (b)  promote  morphological  changes  like  cell 
rounding, (c) be heat stable, and (d) be a component of se- 
rum or cell membrane extracts. 
All of these criteria were met by the bioactive lipid LPA 
(54). LPA is mitogenic for nonneural cells (72, 75, 81, 82), 
produces actin-based stress fiber formation in fibroblasts 
(61),  and  results in  the  retraction  of "neurites"  and  cell 
rounding in neuroblastoma-derived cell lines (40).  It is a 
heat-stable component of serum (61), present at a concen- 
tration of 2-20  ~M, that is bound to albumin (27).  It can 
also  be  produced  from  cell membrane  phospholipids by 
phospholipase A2 (29). 
Vzg-1 Has Predicted Properties of a Receptor for LPA 
The  vzg-1  gene  product meets  the  expected criteria of a 
receptor for LPA.  Vzg-1  encodes  a  GPCR  based on  se- 
Figure 7.  Vzg-1 sense overexpression enhances LPA-induced cell 
rounding and increases [3H]LPA binding to cell membranes. (a) 
Vzg-1 sense strand-transfected cell lines express more protein 
than control cells. Sense-transfected cells (shown for line 3) ex- 
pressed more Vzg-1  than  empty vector (33) or antisense  (17) 
cells, using an cx-Vzg-1  antiserum that specifically  detects a 41-42-kD 
protein not detected by preimmune serum. An identically sized 
protein is detected in adult brain. Equivalent amounts of mem- 
brane protein (5.5/xg) were loaded in each well as determined by 
Bradford assay of the sample, and confirmed by Coomassie stain- 
ing after gel electrophoresis (data not shown) (2). (b) Response 
of stably transfected cell lines after 3 h treatment with 1 p~M 1-ole- 
oyl LPA. Cell lines stably transfected with the sense vzg-1 expres- 
sion construct (lines 3, 7, and 14) showed enhanced responses to 
LPA compared to empty vector control line 33. Antisense cell 
lines (lines 17, 18, and 24) have lower responses to LPA than the 
empty vector control line 33.  * indicates statistically significant 
differences between experimental cells and control line 33 in the 
presence of LPA, with individual pairwise P values ranging from 
P  <  0.05 to P  <  0.001. # indicates statistically significant differ- 
ences  between  experimental cells and  control line 33  without 
LPA stimulation, with individual pairwise P values ranging from 
P  <  0.05 to P  <  0.001. All values represent the mean _+ SEM of 
three to five independent experiments, each done in duplicate. 
(c)  Concentration-response  relationship  of  stably  transfected 
cells to a three to five rain treatment with LPA. Sense transfected 
cells show an increased sensitivity to LPA compared to empty 
vector control cells as demonstrated by a leftward shift of the EC50. 
Antisense transfected cells have identical ECs0 as controls, but 
lowered minimal and maximal responses (Table IV). Curves were 
fitted to data points representing the mean -+ SEM of three inde- 
pendent experiments, each done in duplicate. (d) Vzg-1  overex- 
pression results in increased [3H]LPA binding in membranes from 
sense-transfected ceils (shown for line 3), compared to membranes 
from antisense-expressing cells (shown for line 17). * indicates a 
significant difference from control (P =  0.021), data expressed as 
the mean _+ SEM of four experiments, done in triplicate. 
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Sustained Cell Rounding 
Line 3  Line 7  Line 14 
(percent round,  (percent round,  (percent round, 
Phospholipid  mean -  SEM)  mean -+ SEM)  mean 4- SEM) 
1-Oleoyl LPA  50 -  2.3*  57 ±  2.8*  54 +  1.3" 
1-Stearoyl LPA  33 ±  1.2  55 -  3.1"  35 ±  2.6* 
1-Oleoyl LPE  29 ±  1.3  44 +  1.1  27 ±  1.1 
1-Oleoyl LPG  22 ±  0.71  37 ±  1.2  25 -+ 0.85 
1-Oleoyl LPC  24 ±  2.5  42 -+ 2.0  29 -+ 0.25 
1,2-Dioleoyl PA  27 ±  1.0  43 -  0.85  31  ±  2.1 
Control: medium alone  27 ±  2.8  39 -+  1.7  24 ±  1.6 
Cell lines stably transfected with the vzg-1 sense construct were serum deprived for 
24 h, and then treated with 1 I~M concentrations  of the indicated phospholipids for 3 h. 
Data represent the mean -+ SEM for four independent experiments, each done in du- 
plicate. 
*Indicates statistically significant differences from c0ntrol conditions (P <  0.01 to 
P <  0.001) 
quence homology (57). The ability of this receptor to bind 
[3H]LPA  was  tested  using  membrane  binding  assays. 
Binding studies with LPA are  complicated by the  lipo- 
philic detergent properties of the radioligand, which favor 
partitioning into phospholipid bilayers and micelle forma- 
tion, resulting in substantial levels of nonspecific binding, 
inefficient separation of bound ligand from free, and high 
levels of background. As a result of these technical limita- 
tions, binding assays cannot be  used to  make quantita- 
tively rigorous  measurements  of LPA  binding  sites,  as 
noted in previous studies (26, 71, 74, 77). Because of these 
biophysical properties of LPA and the lack of specific an- 
tagonists (77),  we cannot pharmacologically characterize 
LPA interaction with Vzg-1.  However, vzg-1 overexpres- 
sion was associated with a statistically significant increase 
in specific [3H]LPA membrane binding, a result consistent 
with the functional characterization of vzg-1 as a receptor 
for LPA. 
In TSM neuroblast cell lines overexpressing vzg-1, LPA 
induced  specific,  sustained  neurite  retraction  and  cell 
rounding,  as  reported  previously in  neuroblastoma  cell 
lines (39). Neither other phospholipids nor thrombin pro- 
duced vzg-l-dependent, sustained cell rounding. Charac- 
terization of LPA signaling pathways in vzg-I overexpress- 
ing cell lines revealed a vzg-l-dependent enhancement of 
LPA signaling reflected by a decrease in the ECs0 of LPA- 
induced, Gi-independent cell rounding and Gi-dependent 
inhibition of cAMP formation, as predicted by previous 
Table V. LPA-induced Adenylate Cyclase Inhibition, but Not 
Cell Rounding, is Blocked By PTX 
cAMP percentage of maximum  Percent round cells 
Treatment  response (mean -+ SEM)  (mean -+ SEM) 
Control: medium alone  100  40 ___ 3.2 
LPA  45 ±  3.4*  77 __+ 2.1 * 
LPA +  PTX  84 +  5.0  81  ±  3.5* 
Vzg-1 sense overexpressing cells (cell line 3) were serum deprived 24 h and then stim- 
ulated with 100 nM LPA for 7 min for cAMP assays or with 50 nM LPA for 15 min 
rounding assays. Data represent the mean -+ SEM for three independent experiments 
done in triplicate for cAMP assays or duplicate for rounding assays. 
* Indicates statistically significant differences from control conditions (P <  0.001 ) 
studies (39,  74).  Based  on receptor theory (56),  the in- 
crease in potency seen with sense cells is most simply ex- 
plained by an increase in receptor number, consistent with 
the increase  in protein  levels detected by Western blot 
analysis (Fig. 7 a). Prior studies on LPA receptor distribu- 
tion implicated a 38-40-kD protein highly expressed in the 
adult brain and absent from liver (71, 77). Vzg-1 tissue dis- 
tribution parallels these prior estimates, and, furthermore, 
vzg-1  encodes a  predicted protein  of consistent size (41 
kD), confirmed by anti-Vzg-1 Western blot analysis. 
Therefore, seven different lines of evidence identify the 
vzg-1 gene product as a lysophosphatidic acid receptor: (1) 
identification of vzg-1 as a GPCR gene, (2) vzg-l-depen- 
dent increases in specific [3H]LPA membrane binding, (3) 
vzg-l-dependent decrease of the ECs0 for Gi-independent 
LPA-mediated  cell  rounding,  (4)  vzg-l-dependent  de- 
crease of the ECs0 of LPA-mediated activation of Gi,  (5) 
correspondence between the predicted size of the vzg-1 
gene product and prior estimates of LPA receptor size, (6) 
detection of a  gene product of the correct size in brain, 
with increased levels  of expression  in sense  transfected 
cells, and (7) correlation between tissue expression of vzg-1 
and previous measurements of LPA receptor distribution. 
Vzg-1 and LPA Signaling Have Potential Functions in 
Cortical Neurogenesis 
In  situ  hybridization and  BrdU  double  labeling experi- 
ments demonstrate that vzg-1 is expressed within the em- 
bryonic vz and is both temporally and spatially related to 
the period of cortical neurogenesis (67, 68) (Figs.  1 b and 
5). The identification of the vzg-1 gene product as a recep- 
tor for LPA suggests that LPA signaling mechanisms may 
be important in regulating cortical neurogenesis. Possible 
Table IV. Vzg-1 Sense Overexpression Increases the Potency of  LPA to Induce Cell Rounding and Inhibit Adenylate Cyclase 
Cell rounding  Adenylate cyclase inhibition 
ECso (nM)  Minimum response  Maximum response  ECs0 (riM) 
(95% confidence  -logECso __+_  (Percent round,  (Percent round,  (95% confidence 
Cell Line  interval)  SEM  mean _+ SEM)  mean --. SEM)  interval)  - logEC~o -+ SEM 
Sense (line 3)  1.3 (0.74-2.3)  8.89 -± 0.12  38 --+ 2.1  75 ±  1.2  5.9 (3.0-12)  8.23 -  0.15 
Antisense (line 17)  10 (5.9-18)  7.98 -  0.12  22 _  1.4  54 ±  1.3  34 (13-89)  7.47 ±  0.21 
Control (line 33)  9.0 (5.0-17)  8.04 ±  0.13  35 -+  1.9  77 ±  1.8  39 (13-113)  7.41  -+ 0.23 
Cells were serum deprived for 24 h and then stimulated for 15 min with LPA for cell rounding or for 7 rain for cyclase inhibition. Cell rounding values were calculated from data 
obtained from three independent experiments, each done in duplicate (c.f. Fig. 7 c). Cyclase inhibition values were calculated from data obtained from four independent concentra- 
tion-response experiments, each done in triplicate (data not shown). 
The Journal of Cell Biology, Volume 135, 1996  1080 Figure 8.  Tissue expression of vzg-1 parallels previous estimates 
of LPA receptor tissue distribution. Vzg-1  Northern blot analysis 
(10 txg total RNA)  of adult  tissue  demonstrates  that vzg-1 is 
highly expressed in the adult brain, absent from liver, and present 
in moderate levels in lung, kidney, and spleen, which correlates 
strongly  with  previous  estimates  of LPA receptor distribution 
(71, 77). Variable  expression of the ~-actin loading control (cf. 
Fig. 3) reflects documented differences in expression amongst tis- 
sues  (28), necessitating  use  of the 18S rRNA band,  visualized 
with ethidium bromide. 
functions  of  LPA  in  cortical  neurogenesis,  based  on 
known bioactivities of LPA and biological events occur- 
ring within the vz, include regulation of cytoskeletal events 
such as interkinetic nuclear movement, cell rounding, and 
cleavage plane orientation (13, 40), mitogenesis (discussed 
below), gap junction regulation (34, 49), and influence on 
the binding and assembly of fibronectin (11, 83), which is 
expressed in the embryonic cortex (15, 65). Additionally, 
regulation of apoptosis, recently shown to occur in the vz 
(5), may also be influenced by LPA signaling (47). The ac- 
tual roles of LPA signaling  in the vz, mediated through 
vzg-1, and the source of endogenous ligand remain to be 
determined. 
Vzg-1 Expression Implicates Distinct GPCR-mediated 
Signaling Pathways in Cortical Neurogenesis 
The major  signal  transduction  elements currently impli- 
cated  in  cortical  neurogenesis  operate  through  peptide 
ligand stimulation of the RTK pathway (70). By contrast, 
the bioactive lipid LPA operates through Vzg-1, a GPCR 
family member. Prior studies on LPA signaling have dem- 
onstrated that LPA activates heterotrimeric G proteins, as 
well as  small  GTPases such  as  Rho  that  are  positioned 
downstream  in  the  signaling  pathway  (54).  Therefore, 
many of the initial signaling steps mediated by LPA are 
distinct from the RTK pathway. The presence of vzg-1 ex- 
pression within the cerebral cortical vz indicates the exist- 
ence of a specific role for heterotrimeric G protein signal- 
ing in cortical neurogenesis. 
In view of vzg-1 expression in  the zone of neuroblast 
proliferation, there is a possible role for mitogenic signal- 
ing mediated by LPA in cortical neuron generation. Mito- 
genic effects of LPA appear to involve activation of two 
signaling pathways. The PTX-sensitive pathway, involving 
activation of Gi  and  Ras  (74, 76),  is  probably mediated 
through [3~/snbunit signaling (21, 50, 51). The PTX-insen- 
sitive pathway depends on functional Rho and might lead 
to cell proliferation through activation of a mitogen-acti- 
vated protein kinase cascade (33, 35). Functional Rho is 
also  necessary for  actin-based  cytoskeletal changes  (40, 
61). Our results directly demonstrate the activation of the 
PTX-sensitive Gi-linked pathway,  and indirectly demon- 
strate the activation of the PTX-insensitive pathway lead- 
ing to Rho activatio~n, by vzg-1 mediated LPA signaling in 
neocortical neuroblast cell lines. Thus, a single LPA recep- 
tor appears  to  mediate distinct signaling  pathways.  The 
possible interactions between RTK pathways and these G 
protein mediated events during cortical development will 
be addressed in future studies.  Understanding these and 
related factors controlling cortical neurogenesis may pro- 
vide new insights  into the observed increase in cerebral 
cortical size with phylogenetic ascension. 
In addition to roles in neural development, this LPA re- 
ceptor may participate in  the functioning of many other 
developing and adult tissues and cell types, based on the 
diversity of effects known to be stimulated by LPA. Avail- 
ability of a cDNA encoding a receptor for LPA should fa- 
cilitate the molecular genetic characterization of LPA re- 
ceptor-dependent interactions in  various  cell and  tissue 
types and  allow the  development of agents  that  can  be 
used to manipulate LPA receptor signaling pathways. The 
physiological consequences of LPA receptor elimination 
in mice, the sites of LPA production in vivo, and the possi- 
ble role of this receptor in pathological states remain to be 
determined. 
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